Skip to main content

Trevena plans $50M public stock sale less than a week after new pain drug wins FDA approval

The money will be used for the launch of the Chesterbrook company's first FDA-approved product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.